Abstract:Infections by pathogens that contain DNA trigger the production of type-I interferons and inflammatory cytokines through cyclic GMP–AMP synthase, which produces 2′3′-cyclic GMP–AMP (cGAMP) that binds to and activates stimulator of interferon genes (STING; also known as TMEM173, MITA, ERIS and MPYS)<a href="#ref-CR1">1</a>,<a href="#ref-CR2">2</a>,<a href="#ref-CR3">3</a>,<a href="#ref-CR4">4</a>,<a href="#ref-CR5">5</a>,<a href="#ref-CR6">6</a>,<a href="#ref-CR7">7</a>,<a href="/articles/s41586-019-0998-5#ref-CR8">8</a>. STING is an endoplasmic-reticulum membrane protein that contains four transmembrane helices followed by a cytoplasmic ligand-binding and signalling domain<a href="#ref-CR9">9</a>,<a href="#ref-CR10">10</a>,<a href="#ref-CR11">11</a>,<a href="#ref-CR12">12</a>,<a href="/articles/s41586-019-0998-5#ref-CR13">13</a>. The cytoplasmic domain of STING forms a dimer, which undergoes a conformational change upon binding to cGAMP<a href="/articles/s41586-019-0998-5#ref-CR9">9</a>,<a href="/articles/s41586-019-0998-5#ref-CR14">14</a>. However, it remains unclear how this conformational change leads to STING activation. Here we present cryo-electron microscopy structures of full-length STING from human and chicken in the inactive dimeric state (about 80 kDa in size), as well as cGAMP-bound chicken STING in both the dimeric and tetrameric states. The structures show that the transmembrane and cytoplasmic regions interact to form an integrated, domain-swapped dimeric assembly. Closure of the ligand-binding domain, induced by cGAMP, leads to a 180° rotation of the ligand-binding domain relative to the transmembrane domain. This rotation is coupled to a conformational change in a loop on the side of the ligand-binding-domain dimer, which leads to the formation of the STING tetramer and higher-order oligomers through side-by-side packing. This model of STING oligomerization and activation is supported by our structure-based mutational analyses.

Applications of cryo-EM in drug development for STING

Structural Insights into a Shared Mechanism of Human STING Activation by a Potent Agonist and an Autoimmune Disease-Associated Mutation.

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

Bioactive Modulators Targeting STING Adaptor in Cgas-Sting Pathway

Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities

Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective

[Single-Particle Cryo-Electron Microscopy Opens New Avenues in Structural Biology of G Protein-Coupled Receptor].

Cellular functions of cGAS-STING signaling

Activation of STING by targeting a pocket in the transmembrane domain

Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP–AMP

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Development of small molecule inhibitors/agonists targeting STING for disease

Advances in structure-guided mechanisms impacting on the cGAS-STING innate immune pathway

Activation of STING Based on Its Structural Features

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

Roles of Water Molecules in STING Activation: A Computational Perspective

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Molecular Dynamics Simulations Reveal the Modulated Mechanism of STING Conformation

Chemical regulation of the cGAS-STING pathway

Cgas/sting: Novel Perspectives of the Classic Pathway